Funds holding LIGAND PHARMACEUTICALS INC
4 funds declare a position · 1 ETFs and 3 other funds · 693.9 $ · US53220K2151
Other lines from the same issuer : Ligand Pharmaceuticals Inc (US53220K5048), LIGAND PHARMACEUTICALS INC (US53220K1997), LIGAND PHARMACEUTICALS INC (US53220K1732), LIGAND PHARMACEUTICALS INC (US53220K1815)
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 395,811 | 653.1 $ | as of Mar 31, 2026 · Original filing | |
| 2 | Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 26,087 | 36.5 $ | as of Feb 28, 2026 · Original filing | |
| 3 | Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 1,530 | 2.1 $ | as of Feb 28, 2026 · Original filing | |
| 4 | Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 1,518 | 2.1 $ | as of Feb 28, 2026 · Original filing |
Institutional managers
1 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Ancora Advisors LLC | 12,000 | 16 $ | as of Mar 31, 2026 |